Earnings ·
STERIS raises fiscal 2027 adjusted EPS outlook to $11.35-$11.55 on tariff refunds
STESTERIS plc
STERIS plc reported fiscal 2027 second-quarter revenue of $1.6 billion, up 9% year-over-year, with constant currency organic growth of 8%. Adjusted diluted earnings per share rose to $2.94 from $2.47 in the prior year period, driven by strong performance in its Healthcare and Life Sciences segments. The company announced a targeted restructuring plan expected to generate annualized savings of approximately $9 million. Management updated its full-year fiscal 2027 outlook, raising adjusted EPS expectations to a range of $11.35 to $11.55 from the previous guidance of $11.10 to $11.30, citing stable underlying demand and benefits from tariff refunds received year-to-date.